What's new

Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive

Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive

Feb 20, 2025 - 15:26
 0
Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive
Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive
Read More

Tags:

Previous Article

Samsung Wallet Brings Digital Key Support for Select Volvo and Polestar EVs

Next Article

Valley Children's bets on paid study time to retain nurses

Related Posts

Herbal medicinal product: Anisi aetheroleumArray, C: ongoing call for scientific data

Herbal medicinal product: Anisi aetheroleumArray, C: on...

Feb 14, 2025  0

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Orphan designation: Allogenic umbilical cord-derived os...

Feb 20, 2025  0

Questions and answers on implementation of the medical ...

Feb 9, 2025  0